GIC Sub-Industry »Biotechnology« (200+)
| Symbol | Industry | Market Cap | VRT | Buy Signal | Risk | RS (IBD) | Div. Yield |
|---|---|---|---|---|---|---|---|
| ABBV AbbVie |
Biotechnology
Medicines, Therapies, Injectables |
411B | 38 | -0.09 | 50 | 56 | 3.3% |
| AMGN Amgen |
Biotechnology
Biologics, Treatments, Therapies |
198B | 60 | -0.06 | 57 | 78 | 3.1% |
| GILD Gilead Sciences |
Biotechnology
Antivirals, Oncology, Rare Diseases |
180B | 64 | -0.24 | 83 | 81 | 2.8% |
| NOV Novo Nordisk |
Biotechnology
Diabetes, Obesity, Rare Disease |
171B | 38 | -1.38 | 83 | 4 | 2.8% |
| VRTX Vertex |
Biotechnology
Medicines, Therapies, Treatments |
116B | 54 | -0.33 | 90 | 54 | - |
| REGN Regeneron |
Biotechnology
Eye Disease, Asthma, Cancer |
80.9B | 52 | -0.51 | 99 | 73 | 0.5% |
| ARGX argenx |
Biotechnology
Biologics, Treatments, Autoimmune |
46.0B | 64 | -0.53 | 75 | 33 | - |
| HLN Haleon |
Biotechnology
Oral Care, Vitamins, Pain Relief |
45.8B | 46 | -0.76 | 84 | 37 | 1.8% |
| ALNY Alnylam |
Biotechnology
RNAi Therapeutics, Onpattro |
42.8B | 54 | -0.53 | 34 | 24 | - |
| ONC BeiGene |
Biotechnology
Cancer Therapies, Immunotherapy |
35.3B | 46 | -1.05 | 43 | 30 | - |
| INSM Insmed |
Biotechnology
Rare Disease Therapies, Lung |
30.9B | 32 | -0.36 | 32 | 67 | - |
| NTRA Natera |
Biotechnology
Prenatal Screening, Cancer |
29.1B | 58 | -0.21 | 36 | 49 | - |
| BIIB Biogen |
Biotechnology
Neurology Drugs, Biosimilars, Rare |
27.6B | 54 | -0.42 | 90 | 77 | - |
| UTHR United Therapeutics |
Biotechnology
Treating Pulmonary Arterial |
23.5B | 62 | -0.21 | 77 | 88 | - |
| ROIV Roivant Sciences |
Biotechnology
Medicines, Therapies, Antibodies |
21.3B | 51 | 0.01 | 92 | 97 | - |
| BNTX BioNTech SE |
Biotechnology
Cancer, Vaccines, Immunotherapy |
21.1B | 27 | -0.45 | 85 | 24 | - |
| MRNA Moderna |
Biotechnology
Vaccines, Oncology, Rare |
20.7B | 39 | 0.28 | 35 | 96 | - |
| EXAS EXACT Sciences |
Biotechnology
Cancer Tests, Genetic Testing |
19.8B | 54 | 0.36 | 33 | 93 | - |
| RVMD Revolution |
Biotechnology
Cancer Therapies, Drug |
19.5B | 45 | -1.06 | 96 | 96 | - |
| INCY Incyte |
Biotechnology
Cancer Therapies, Dermatology |
19.1B | 67 | -0.23 | 85 | 68 | - |
| GMAB Genmab AS |
Biotechnology
Antibody Therapies, Cancer Drugs |
17.2B | 47 | -0.65 | 69 | 41 | - |
| ASND Ascendis Pharma AS |
Biotechnology
Endocrinology, Therapies, Rare |
14.8B | 51 | -0.43 | 30 | 77 | - |
| BBIO BridgeBio Pharma |
Biotechnology
Genetic Medicines, Small |
14.4B | 40 | -0.41 | 36 | 87 | - |
| BIM Biomerieux |
Biotechnology
Diagnostic Tests, Culture Media |
13.0B | 41 | -0.90 | 95 | 16 | 0.7% |
| NBIX Neurocrine |
Biotechnology
Neurological Drugs, Endocrine |
13.0B | 47 | -0.55 | 86 | 28 | - |
| ERF Eurofins |
Biotechnology
Testing, Laboratory, Analysis |
13.0B | 58 | -0.76 | 79 | 56 | 1.1% |
| IONS Ionis |
Biotechnology
RNA Medicines, Genetic Diseases |
12.2B | 46 | -1.09 | 61 | 89 | - |
| BMRN Biomarin |
Biotechnology
Rare Disease Therapies, Enzyme |
11.8B | 40 | -0.55 | 94 | 46 | - |
| SMMT Summit Therapeutics |
Biotechnology
Oncology Drug, Immunotherapy |
11.7B | 14 | -1.58 | 96 | 15 | - |
| EXEL Exelixis |
Biotechnology
Cancer Drugs, Targeted Therapies |
11.2B | 51 | -0.02 | 93 | 45 | - |
| MDGL Madrigal |
Biotechnology
Liver Drug, MASH Treatment |
9.83B | 27 | -0.15 | 32 | 56 | - |
| QIA QIAGEN |
Biotechnology
Diagnostics, Research Tools, Lab |
9.35B | 38 | -1.55 | 83 | 24 | 5.3% |
| PRAX Praxis Precision |
Biotechnology
Ulixacaltamide, Vormatrigine |
8.65B | 46 | -0.28 | 81 | 99 | - |
| ARWR Arrowhead |
Biotechnology
RNAi, Hepatic, Metabolic |
8.50B | 58 | -0.76 | 30 | 98 | - |
| PCVX Vaxcyte |
Biotechnology
Vaccines, Pneumococcal, Bacterial |
8.46B | 30 | -0.18 | 95 | 84 | - |
| ABVX Abivax American |
Biotechnology
Obefazimod |
8.19B | 32 | -0.26 | 45 | 99 | - |
| ABVX Abivax |
Biotechnology
Obefazimod, UlcerativeColitis |
8.05B | 34 | -0.49 | 44 | 99 | - |
| HALO Halozyme |
Biotechnology
Enzymes, Drug Delivery, Biologics |
7.95B | 48 | -0.78 | 83 | 37 | - |
| NUVL Nuvalent |
Biotechnology
Cancer Therapies, Drug Candidates |
7.82B | 43 | -0.36 | 94 | 67 | - |
| CYTK Cytokinetics |
Biotechnology
Muscle Activators, Muscle |
7.60B | 37 | -0.79 | 36 | 79 | - |
| KRYS Krystal Biotech |
Biotechnology
Genetic Medicines, Skin |
7.42B | 57 | -0.12 | 87 | 88 | - |
| KYMR Kymera Therapeutics |
Biotechnology
Drug Discovery, Protein |
6.82B | 45 | -0.79 | 92 | 89 | - |
| BLTE Belite Bio |
Biotechnology
Eye Disease, Liver Disease |
6.72B | 44 | -0.33 | 95 | 97 | - |
| ACLX Arcellx |
Biotechnology
Cancer Therapies, Immunotherapies |
6.69B | 47 | 0.31 | 90 | 93 | - |
| RYTM Rhythm |
Biotechnology
Rare Diseases, Obesity |
6.39B | 38 | -0.28 | 45 | 70 | - |
| COGT Cogent Biosciences |
Biotechnology
Cancer Drugs, Genetic Therapies |
5.95B | 49 | 0.12 | 89 | 99 | - |
| PTGX Protagonist |
Biotechnology
Oral Peptides, Injectable |
5.88B | 49 | 0.07 | 40 | 87 | - |
| PTCT PTC Therapeutics |
Biotechnology
Rare Disease Drugs, Gene Therapy |
5.68B | 55 | -0.60 | 64 | 43 | - |
| MIRM Mirum |
Biotechnology
Rare Disease Treatments, Liver |
5.49B | 60 | -0.28 | 40 | 92 | - |
| CRSP Crispr Therapeutics |
Biotechnology
Gene Editing, Cell Therapy, Drug |
5.42B | 22 | -0.95 | 91 | 31 | - |
| CELC Celcuity |
Biotechnology
Drug Candidates, Diagnostics |
5.33B | 60 | 0.20 | 89 | 99 | - |
| IMVT Immunovant |
Biotechnology
Antibodies, Treatments, Diseases |
5.23B | 32 | -0.21 | 36 | 80 | - |
| CGON CG Oncology |
Biotechnology
Cancer Therapies, Bladder Cancer |
5.22B | 41 | 0.70 | 40 | 97 | - |
| XENE Xenon |
Biotechnology
Neurological Therapeutics |
5.22B | 31 | -0.10 | 25 | 91 | - |
| APGE Apogee |
Biotechnology
Biologics, Antibodies, Treatments |
5.19B | 45 | 0.22 | 96 | 91 | - |
| SRRK Scholar Rock |
Biotechnology
Antibody, Inhibitor, Myostatin |
5.08B | 25 | -1.00 | 86 | 62 | - |
| ERAS Erasca |
Biotechnology
Cancer Therapies, Drug |
4.79B | 44 | 0.22 | 41 | 99 | - |
| ALKS Alkermes |
Biotechnology
Schizophrenia, Bipolar, Alcohol |
4.77B | 30 | -0.81 | 74 | 26 | - |
| DIA DiaSorin S.p.A. |
Biotechnology
Diagnostic Kits, Molecular |
4.76B | 38 | -0.97 | 70 | 16 | 1.3% |
| TGTX TG Therapeutics |
Biotechnology
Antibodies, Cancer Treatments |
4.67B | 19 | -1.33 | 31 | 13 | - |
| INDV Indivior Ordinary |
Biotechnology
Extended-Release Injection |
4.03B | 66 | 0.26 | 45 | 94 | - |
| CNTA Centessa |
Biotechnology
Medicines, Treatments |
4.03B | 42 | -0.04 | 39 | 89 | - |
| LGND Ligand |
Biotechnology
Antiviral, Oncology, Nephrology |
4.03B | 63 | 0.22 | 80 | 90 | - |
| GPCR Structure |
Biotechnology
Obesity Drugs, Fibrosis Drugs |
4.00B | 50 | -0.91 | 96 | 96 | - |
| CRNX Crinetics |
Biotechnology
Paltusotine, Atumelnant, CRN09682 |
3.91B | 20 | -1.03 | 42 | 26 | - |
| ACAD ACADIA |
Biotechnology
Antipsychotic, Trofinetide |
3.84B | 27 | -0.81 | 33 | 27 | - |
| VKTX Viking Therapeutics |
Biotechnology
Metabolic Therapies, Endocrine |
3.81B | 26 | -0.68 | 91 | 70 | - |
| ADMA ADMA Biologics |
Biotechnology
Biologics, Therapeutics, Plasma |
3.67B | 40 | -0.67 | 52 | 13 | - |
| KNSA Kiniksa |
Biotechnology
Cardiovascular Therapies, Skin |
3.58B | 54 | 0.05 | 56 | 89 | - |
| LEGN Legend Biotech |
Biotechnology
Cell Therapies, Oncology, Cancer |
3.50B | 13 | -1.22 | 38 | 5 | - |
| NAMS NewAmsterdam |
Biotechnology
Cardiometabolic Therapies |
3.43B | 30 | -0.80 | 30 | 62 | - |
| DNTH Dianthus |
Biotechnology
Antibodies, Therapeutics |
3.42B | 37 | -0.41 | 40 | 99 | - |
| ALMS Alumis |
Biotechnology
TYK2 Inhibitor, Autoimmune Drug |
3.35B | 45 | -0.26 | 76 | 99 | - |
| DYN Dyne Therapeutics |
Biotechnology
Muscle Disease, Therapeutics |
3.30B | 45 | -1.13 | 84 | 74 | - |
| SYRE Spyre Therapeutics |
Biotechnology
Antibodies, Inflammatory Disease |
3.26B | 47 | 0.19 | 86 | 96 | - |
| DNLI Denali Therapeutics |
Biotechnology
Neuro Drugs, Enzyme Therapy |
3.08B | 42 | -0.11 | 95 | 82 | - |
| EWTX Edgewise |
Biotechnology
Muscle Therapies, Cardiac |
3.05B | 32 | -0.33 | 96 | 92 | - |
| CPRX Catalyst |
Biotechnology
Rare Disease Treatments, Seizure |
2.98B | 54 | -0.11 | 81 | 48 | - |
| ARQT Arcutis |
Biotechnology
Skin Treatments, Topical Creams |
2.98B | 44 | -0.86 | 33 | 77 | - |
| TWST Twist Bioscience |
Biotechnology
Synthetic DNA, Gene Synthesis |
2.96B | 29 | -1.47 | 41 | 86 | - |
| IDYA Ideaya Biosciences |
Biotechnology
Oncology Therapeutics, Drug |
2.91B | 36 | -0.57 | 39 | 82 | - |
| VRDN Viridian |
Biotechnology
Antibodies, Rare Diseases |
2.90B | 45 | -0.31 | 96 | 86 | - |
| VERA Vera Therapeutics |
Biotechnology
Biologics, Antibodies, Therapies |
2.87B | 46 | -0.42 | 96 | 84 | - |
| RCUS Arcus Biosciences |
Biotechnology
Antibody, Inhibitor, Cancer |
2.77B | 44 | -0.45 | 63 | 95 | - |
| BEAM Beam Therapeutics |
Biotechnology
Gene Editing, Therapeutics, RNA |
2.70B | 36 | -0.46 | 91 | 61 | - |
| VCYT Veracyte |
Biotechnology
Cancer Tests, Genomic Analysis |
2.65B | 31 | -0.85 | 38 | 24 | - |
| TVTX Travere |
Biotechnology
Sparsentan, Tiopronin, Filspari |
2.51B | 54 | -0.28 | 34 | 75 | - |
| APLS Apellis |
Biotechnology
Eye Treatments, Blood Treatments |
2.48B | 28 | -1.22 | 35 | 12 | - |
| IMNM Immunome |
Biotechnology
Cancer Therapies, Drug Candidates |
2.41B | 48 | 0.21 | 96 | 95 | - |
| TNGX Tango Therapeutics |
Biotechnology
Oncology Drugs, Cancer Treatments |
2.35B | 48 | 0.06 | 84 | 99 | - |
| IRON Disc Medicine |
Biotechnology
Blood Disorders, Drug Development |
2.33B | 30 | -1.00 | 96 | 23 | - |
| GLPG Galapagos |
Biotechnology
Oncology Drugs, Immunology Drugs |
2.26B | 52 | -0.42 | 78 | 53 | - |
| IOVA Iovance |
Biotechnology
Cell Therapies, Cancer Treatments |
2.23B | 29 | -1.06 | 35 | 94 | - |
| DAWN Day One |
Biotechnology
Cancer Drugs, Clinical Trials |
2.20B | 37 | 0.44 | 28 | 99 | - |
| ZLAB Zai Lab |
Biotechnology
Cancer Drugs, Autoimmune Drugs |
2.16B | 11 | -1.21 | 34 | 9 | - |
| SLNO Soleno Therapeutics |
Biotechnology
Rare diseases, Tablets |
2.13B | 36 | -1.92 | 81 | 5 | - |
| SNDX Syndax |
Biotechnology
Cancer Therapies, Leukemia |
2.11B | 35 | -0.19 | 27 | 93 | - |
| MLYS Mineralys |
Biotechnology
Medicines, Treatments, Aldosterone |
2.10B | 50 | -0.39 | 81 | 76 | - |
| RARE Ultragenyx |
Biotechnology
Biologics, Gene Therapy, Enzyme |
2.05B | 13 | -1.06 | 45 | 3 | - |
| CLDX Celldex |
Biotechnology
Antibodies, Therapeutics |
2.05B | 30 | -0.52 | 40 | 79 | - |
| STOK Stoke Therapeutics |
Biotechnology
Genetic Therapies, Antisense |
2.03B | 55 | 0.37 | 35 | 98 | - |
| MESO Mesoblast |
Biotechnology
Cell Therapy, Inflammation, Heart |
1.94B | 12 | -1.16 | 33 | 35 | - |
| ZBIO Zenas BioPharma |
Biotechnology
Antibodies, Therapies, Immunology |
1.91B | 46 | -0.56 | 88 | 91 | - |
| AUPH Aurinia |
Biotechnology
Autoimmune Therapies, Lupus |
1.91B | 61 | 0.31 | 35 | 82 | - |
| ZYME Zymeworks Common |
Biotechnology
Antibody Therapeutics, Cancer |
1.89B | 36 | -0.90 | 40 | 87 | - |
| NANO Nanobiotix S.A |
Biotechnology
Cancer Therapy, Nanoparticles |
1.87B | 32 | -0.92 | 30 | 99 | - |
| BCRX BioCryst |
Biotechnology
Influenza Treatments, Rare Disease |
1.87B | 52 | -0.14 | 31 | 45 | - |
| RXRX Recursion |
Biotechnology
Drug Discovery, Clinical Trials |
1.83B | 18 | -1.36 | 45 | 6 | - |
| TYRA Tyra Biosciences |
Biotechnology
Biologics, Therapies, Oncology |
1.82B | 48 | 0.71 | 96 | 99 | - |
| RLAY Relay Therapeutics |
Biotechnology
Oncology Drugs, Genetic Drugs |
1.77B | 55 | 0.25 | 96 | 98 | - |
| SRPT Sarepta |
Biotechnology
Exon-Skipping Injection, Gene |
1.75B | 16 | -0.97 | 44 | 4 | - |
| ANAB AnaptysBio |
Biotechnology
Antibodies, Therapeutics |
1.72B | 71 | 0.86 | 41 | 99 | - |
| VCEL Vericel Ord |
Biotechnology
Cellular Therapies, Skin |
1.71B | 38 | -0.72 | 78 | 16 | - |
| SION Sionna |
Biotechnology
Drug Development, Clinical Trials |
1.69B | 50 | -0.34 | 88 | 91 | - |
| PHVS Pharvaris BV |
Biotechnology
Rare Disease Therapies, Angioedema |
1.68B | 47 | -0.69 | 88 | 82 | - |
| IMCR Immunocore Holdings |
Biotechnology
Cancer Drugs, Viral Cures |
1.67B | 24 | -1.23 | 79 | 22 | - |
| CAPR Capricor |
Biotechnology
Cell Therapies, Exosome Therapies |
1.67B | 45 | 0.01 | 32 | 99 | - |
| AGIO Agios Pharm |
Biotechnology
Medicines, Anemias, Thalassemia |
1.66B | 21 | -0.38 | 41 | 20 | - |
| NRIX Nurix Therapeutics |
Biotechnology
Cancer Drugs, Autoimmune Drugs |
1.64B | 40 | 0.34 | 96 | 69 | - |
| ORKA Oruka Therapeutics |
Biotechnology
Antibodies, Inflammation |
1.63B | 46 | -0.92 | 81 | 96 | - |
| NUVB Nuvation Bio |
Biotechnology
Cancer Drugs, Lung Cancer, Solid |
1.63B | 39 | -1.02 | 33 | 86 | - |
| NVAX Novavax |
Biotechnology
Vaccines, Infectious Diseases |
1.63B | 48 | -0.12 | 35 | 89 | - |
| OCS Oculis Holding |
Biotechnology
Eye Treatments, Drug Candidates |
1.59B | 31 | -0.28 | 44 | 88 | - |
| NTLA Intellia |
Biotechnology
In Vivo, Ex Vivo, CRISPR, CAR-T |
1.59B | 31 | -0.27 | 34 | 86 | - |
| ORIC Oric |
Biotechnology
Cancer Therapies, Drug |
1.54B | 49 | -0.96 | 90 | 80 | - |
| KOD Kodiak Sciences |
Biotechnology
Retinal Therapeutics, Antibody |
1.53B | 58 | -0.17 | 94 | 99 | - |
| ARDX Ardelyx |
Biotechnology
IBS Therapy, Phosphate Reducer |
1.52B | 32 | -1.05 | 32 | 49 | - |
| VIR Vir Biotechnology |
Biotechnology
Antibodies, Therapies, Vaccines |
1.50B | 34 | 0.29 | 34 | 92 | - |
| MEDCL Medincell |
Biotechnology
Injectables, Pharmaceuticals |
1.47B | 54 | -0.84 | 39 | 56 | - |
| ATAI ATAI Life Sciences |
Biotechnology
Mental Health, Psychedelics |
1.41B | 30 | -1.29 | 29 | 88 | - |
| IMTX Immatics |
Biotechnology
Cancer Therapies, Cell Therapy |
1.41B | 39 | -1.04 | 40 | 88 | - |
| BHVN Biohaven |
Biotechnology
Neurological Therapies, Oncology |
1.37B | 22 | -1.79 | 96 | 6 | - |
| PGEN Precigen |
Biotechnology
Gene Therapies, Cell Therapies |
1.36B | 45 | -0.84 | 35 | 84 | - |
| GLUE Monte Rosa |
Biotechnology
Drug Discovery, Cancer Treatments |
1.35B | 49 | -0.44 | 42 | 98 | - |
| CRVS Corvus |
Biotechnology
Cancer Treatments, Immune |
1.32B | 38 | -0.25 | 35 | 99 | - |
| MBX MBX Biosciences |
Biotechnology
Peptide Therapies, Endocrine |
1.30B | 49 | -0.68 | 96 | 97 | - |
| MLTX MoonLake |
Biotechnology
Inflammatory Therapies, Skin |
1.30B | 22 | -1.35 | 96 | 6 | - |
| BCAX Bicara |
Biotechnology
Cancer Drugs, Antibodies, Therapies |
1.28B | 37 | -0.46 | 96 | 86 | - |
| TSHA Taysha Gene |
Biotechnology
Gene Therapies, Nervous System |
1.25B | 48 | -0.17 | 96 | 91 | - |
| ALVO Alvotech |
Biotechnology
Biologics, Therapeutics |
1.25B | 14 | -2.07 | 35 | 1 | - |
| IVA Inventiva S.A |
Biotechnology
Lanifibranor, Odiparcil, TGF-ß |
1.24B | 39 | -0.60 | 35 | 92 | - |
| DBVT DBV Technologies |
Biotechnology
Allergy Treatments, Patches |
1.20B | 36 | -0.84 | 30 | 98 | - |
| AVBP ArriVent |
Biotechnology
Firmonertinib, ARR-217, ARR-002 |
1.10B | 31 | -1.12 | 81 | 52 | - |
| SVRA Savara |
Biotechnology
Rare Diseases, Respiratory |
1.07B | 53 | -0.10 | 81 | 90 | - |
| PHARM Pharming |
Biotechnology
Rare Disease Therapies, Protein |
1.07B | 54 | -0.34 | 60 | 76 | - |
| ABCL Abcellera Biologics |
Biotechnology
Antibody Drugs, Drug Discovery |
1.05B | 50 | -0.56 | 80 | 50 | - |
| INBX Inhibrx |
Biotechnology
Biologics, Therapeutics, Cancer |
1.04B | 39 | -0.72 | 41 | 99 | - |
| BBOT BridgeBio Oncology |
Biotechnology
Small Molecules, Cancer Drugs |
1.01B | 22 | -1.99 | 96 | 15 | - |
| CMPX Compass |
Biotechnology
Tovecimig, CTX-471, CTX-8371 |
991M | 45 | -1.46 | 81 | 92 | - |
| GHRS GH Research |
Biotechnology
Depression Treatments, Drug |
988M | 40 | -0.04 | 80 | 79 | - |
| GERN Geron |
Biotechnology
Cancer Drugs, Therapeutics |
977M | 22 | -0.96 | 34 | 62 | - |
| URGN UroGen Pharma |
Biotechnology
Cancer Drugs, Hydrogel Technology |
969M | 37 | -0.79 | 35 | 78 | - |
| SLS Sellas Life |
Biotechnology
Cancer drugs, Immunotherapy, Small |
942M | 49 | -0.88 | 88 | 99 | - |
| CGEM Cullinan Oncology |
Biotechnology
Cancer Drugs, Autoimmune Drugs |
930M | 52 | -0.34 | 76 | 91 | - |
| VLA Valneva SE |
Biotechnology
Vaccines, Infectious diseases |
917M | 36 | -1.56 | 35 | 84 | - |
| OPK Opko Health |
Biotechnology
Diagnostics, Pharmaceuticals |
906M | 13 | -0.68 | 31 | 14 | - |
| ABUS Arbutus Biopharma |
Biotechnology
Hepatitis B, RNAi, Immune Response |
906M | 35 | -0.92 | 35 | 56 | - |
| SPRY ARS |
Biotechnology
Neffy, Nasal, Epinephrine |
896M | 15 | -1.31 | 37 | 9 | - |
| KALV Kalvista |
Biotechnology
Drug Therapies, Small Molecules |
874M | 41 | -0.45 | 29 | 75 | - |
| CDNA CareDx |
Biotechnology
Transplant Testing, Gene |
873M | 27 | -0.83 | 32 | 23 | - |
| CTMX CytomX Therapeutics |
Biotechnology
Oncology Drugs, Biologics |
852M | 49 | 0.09 | 39 | 99 | - |
| JANX Janux Therapeutics |
Biotechnology
Cancer Drugs, Immunotherapies |
842M | 11 | -0.43 | 30 | 6 | - |
| MPLT MapLight |
Biotechnology
CNS Treatments, Drug Candidates |
840M | 36 | 0.03 | 88 | 33 | - |
| SANA Sana Biotechnology |
Biotechnology
Cell Therapy, Diabetes Treatment |
839M | 24 | -1.30 | 76 | 20 | - |
| XNCR Xencor |
Biotechnology
Antibodies, Biologics |
830M | 19 | -0.87 | 45 | 30 | - |
| CSTL Castle Biosciences |
Biotechnology
Melanoma, Squamous-Cell, Uveal |
803M | 45 | -0.70 | 52 | 43 | - |
| DRUG Bright Minds |
Biotechnology
Drug Development, Serotonin |
787M | 49 | -0.49 | 93 | 92 | - |
| KURA Kura Oncology |
Biotechnology
Cancer Drugs, Leukemia Treatment |
780M | 21 | -1.13 | 39 | 51 | - |
| ANNX Annexon |
Biotechnology
Biologics, Small Molecules |
769M | 58 | -0.69 | 88 | 94 | - |
| OCGN Ocugen |
Biotechnology
Gene Therapy, Vaccines, Cell |
754M | 49 | 0.32 | 87 | 98 | - |
| BTX BlackRock |
Biotechnology
Technology, Private Equity |
754M | 19 | -0.37 | 55 | 34 | 12.4% |
| ESPR Esperion |
Biotechnology
Cholesterol Medication |
727M | 33 | -1.81 | 24 | 72 | - |
| PRME Prime Medicine |
Biotechnology
Gene Editing, Genetic Therapies |
724M | 46 | -0.97 | 85 | 89 | - |
| LXRX Lexicon |
Biotechnology
Drugs, Treatments, Research |
715M | 40 | 0.24 | 34 | 98 | - |
| REPL Replimune |
Biotechnology
Cancer Therapies, Immunotherapies |
713M | 10 | -1.38 | 38 | 16 | - |
| TECX Tectonic |
Biotechnology
Biologics, Proteins, Antibodies |
674M | 47 | -0.21 | 91 | 94 | - |
| MDXG MiMedx |
Biotechnology
Placental Allografts, Amniotic |
669M | 38 | -1.44 | 89 | 3 | - |
| MGTX MeiraGTx Holdings |
Biotechnology
Gene Therapies, Ocular Treatments |
629M | 29 | -0.51 | 33 | 37 | - |
| VOR Vor Biopharma |
Biotechnology
Cell Therapies, Gene Therapies |
628M | 30 | -1.17 | 96 | 86 | - |
| SLDB Solid Biosciences |
Biotechnology
Gene Therapy, Dystrophy |
625M | 43 | 0.11 | 92 | 88 | - |
| ALLO Allogene |
Biotechnology
CD19, B-cell, leukemia, lymphoma |
609M | 36 | -0.63 | 36 | 94 | - |
| IRWD Ironwood |
Biotechnology
GI Therapies, Rare Disease, Pain |
595M | 54 | -1.19 | 30 | 98 | - |
| LRMR Larimar |
Biotechnology
Rare Disease Treatments, Peptide |
589M | 55 | -1.05 | 87 | 87 | - |
| RCKT Rocket |
Biotechnology
Gene Therapy, AAV, Lentiviral |
575M | 31 | -0.39 | 83 | 84 | - |
| DSGN Design Therapeutics |
Biotechnology
Small Molecules, Genetic Diseases |
575M | 46 | -0.02 | 45 | 94 | - |
| DRTS Alpha Tau Medical |
Biotechnology
Cancer Therapy, Radiation Therapy |
572M | 48 | -0.10 | 96 | 96 | - |
| LXEO Lexeo |
Biotechnology
Gene Therapy, Cardiovascular |
543M | 54 | -0.59 | 96 | 83 | - |
| LYEL Lyell Immunopharma |
Biotechnology
Cell Therapy, Cancer Treatment |
542M | 45 | -0.40 | 96 | 92 | - |
| RGNX Regenxbio |
Biotechnology
Gene Therapy, Drug Candidates |
525M | 26 | -1.03 | 44 | 23 | - |
| RIGL Rigel |
Biotechnology
Cancer Drugs, Blood Disorders |
524M | 43 | -1.09 | 35 | 23 | - |
| PRTA Prothena |
Biotechnology
Antibody, Vaccine |
516M | 26 | -0.22 | 81 | 59 | - |
| FDMT 4D Molecular |
Biotechnology
Gene Therapy, Drug Development |
507M | 54 | -0.20 | 93 | 84 | - |
| ZVRA Zevra Therapeutics |
Biotechnology
KP1077, Celiprolol, AZSTARYS |
506M | 48 | -0.23 | 30 | 77 | - |
| KYTX Kyverna |
Biotechnology
Cell Therapy, Autoimmune Disease |
501M | 48 | 0.02 | 92 | 98 | - |
| IMMX Immix Biopharma |
Biotechnology
Cell Therapy, Cancer Treatment |
492M | 42 | -0.06 | 30 | 99 | - |
| CLYM Climb Bio |
Biotechnology
Antibodies, Therapies, Diseases |
490M | 44 | -0.22 | 81 | 99 | - |
| DBV DBV Technologies |
Biotechnology
Peanut Patch, Milk Patch |
486M | 40 | -0.93 | 38 | 98 | - |
| ALT Altimmune |
Biotechnology
Obesity Treatments, Liver Disease |
483M | 12 | -1.02 | 45 | 7 | - |
| IVVD Invivyd |
Biotechnology
Antibodies, Vaccines, Treatments |
482M | 41 | -0.92 | 45 | 88 | - |
| TRDA Entrada |
Biotechnology
Drug Delivery, RNA Therapeutics |
482M | 42 | 0.04 | 96 | 91 | - |